CVS Health Corp (CVS) Stock Forecast
US · Healthcare
Current price
$104.66
Market cap
$133.54B
Mean price target
$105.38
Implied upside
0.7%
Key takeaways
- Analysts rate CVS Health Corp a “Strong Buy”, with a mean price target of $105.38 — about 0.7% upside from the current $104.66, based on 26 analysts.
- CVS is trading near its 52-week high, at 99% of the $58.50–$104.94 band.
Analyst consensus
| Consensus rating | Strong Buy |
|---|---|
| Number of analysts | 26 |
| Mean target | $105.38 |
| High target | $140.00 |
| Low target | $79.00 |
| Rating split (SB / B / H / S / SS) | 7 / 18 / 4 / 0 / 0 |
Price & trading
| Current price | $104.66 |
|---|---|
| Previous close | $101.87 |
| 52-week high | $104.94 |
| 52-week low | $58.50 |
| 50-day average | $90.11 |
| Beta | 0.62 |
See the full CVS breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current CVS Health Corp (CVS) share price?
- CVS Health Corp last traded at $104.66 with a market capitalisation of about $133.5B.
- What is the analyst price target for CVS?
- The mean analyst price target for CVS Health Corp is $105.38, roughly 0.7% above the latest price. The current consensus rating is “Strong Buy”.
- Where can I see CVS Health Corp's full financial metrics?
- Luminoso tracks CVS's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.